Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression

Long-Term Maintenance With Intramuscular Ketamine for Treatment-Resistant Bipolar II Depression

(2012) Cristina Cusin et al.   AMERICAN JOURNAL OF PSYCHIATRY

Ketamine for Depression: Where Do We Go from Here?

(2012) Marije aan het Rot et al.   BIOLOGICAL PSYCHIATRY

Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial

(2012) Carlos A. Zarate et al.   BIOLOGICAL PSYCHIATRY

Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study

(2012) Lobna Ibrahim et al.   NEUROPSYCHOPHARMACOLOGY

Synaptic Dysfunction in Depression: Potential Therapeutic Targets

(2012) R. S. Duman et al.   SCIENCE

Dose- and Exposure-Response to Ketamine in Depression

(2011) Paul Glue et al.   BIOLOGICAL PSYCHIATRY

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS

(2011) Gerald W. Valentine et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression

(2010) Nancy Diazgranados et al.   ARCHIVES OF GENERAL PSYCHIATRY

Ketamine for the treatment of chronic non-cancer pain

(2010) Ingeborg Noppers et al.   EXPERT OPINION ON PHARMACOTHERAPY

Oral Ketamine for the Rapid Treatment of Depression and Anxiety in Patients Receiving Hospice Care

(2010) Scott A. Irwin et al.   JOURNAL OF PALLIATIVE MEDICINE

Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

(2009) Marije aan het Rot et al.   BIOLOGICAL PSYCHIATRY

Use of oral ketamine in chronic pain management: A review

(2009) Maren I. Blonk et al.   EUROPEAN JOURNAL OF PAIN

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial

(2009) Sanjay J. Mathew et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Oral Administration of the NMDA Receptor Antagonist S-Ketamine as Add-On Therapy of Depression: A Case Series

(2009) G. Paslakis et al.   PHARMACOPSYCHIATRY